| 11/16/2026 11:58 AM | Janus Henderson Group Ltd. (1274173) Filed by Protara Therapeutics (1359931) Subject | Form SCHEDULE 13G/A | |
| 11/06/2026 7:05 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/06/2026 7:10 AM | Protara Therapeutics (1359931) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/13/2026 11:47 AM | Janus Henderson Group Ltd. (1274173) Filed by Protara Therapeutics (1359931) Subject | Form SCHEDULE 13G/A | |
| 08/11/2026 3:15 PM | Protara Therapeutics (1359931) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/11/2026 7:10 AM | Protara Therapeutics (1359931) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/11/2026 7:05 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/07/2026 5:42 PM | MILLENNIUM MANAGEMENT LLC (1273087) Filed by Protara Therapeutics (1359931) Subject | Form SCHEDULE 13G/A | |
| 06/29/2026 4:02 PM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2026 3:05 PM | BESHAR LUKE M (1192128) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:05 PM | Flannelly Barry P (1615842) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 06/16/2026 3:05 PM | GARCEAU ROGER (1451767) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:05 PM | Huang Jane (1683913) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:05 PM | Protara Therapeutics (1359931) Issuer SARGEN GREGORY (1227835) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:05 PM | Protara Therapeutics (1359931) Issuer Smith Cynthia (1609480) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:05 PM | Protara Therapeutics (1359931) Issuer Solomon Michael Edward (1799320) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2026 3:05 PM | Levy Richard S (1454983) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 3:05 PM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/25/2026 11:15 PM | Protara Therapeutics (1359931) Filer | Form EFFECT | |
| 05/15/2026 11:39 AM | JANUS HENDERSON GROUP PLC (1274173) Filed by Protara Therapeutics (1359931) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 7:10 AM | Protara Therapeutics (1359931) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2026 7:05 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 3:05 PM | Protara Therapeutics (1359931) Filer | Form DEF 14A | |
| 04/23/2026 7:41 PM | 667, L.P. (1551139) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/23/2026 7:42 PM | Baker Brothers Life Sciences LP (1363364) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/17/2026 3:15 PM | Protara Therapeutics (1359931) Filer | Form PRE 14A | |
| 04/09/2026 4:25 PM | Protara Therapeutics (1359931) Issuer Zummo Jacqueline (1798929) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 9:32 AM | Protara Therapeutics (1359931) Subject Zummo Jacqueline (1798929) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/30/2026 7:00 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/10/2026 7:06 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/10/2026 7:11 AM | Protara Therapeutics (1359931) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/06/2026 4:50 PM | Baker Brothers Life Sciences LP (1363364) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 4:51 PM | 667, L.P. (1551139) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/06/2026 3:15 PM | Protara Therapeutics (1359931) Filer | Form 424B7 | |
| 03/04/2026 7:35 PM | Baker Brothers Life Sciences LP (1363364) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/04/2026 7:37 PM | 667, L.P. (1551139) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/02/2026 3:19 PM | MILLENNIUM MANAGEMENT LLC (1273087) Filed by Protara Therapeutics (1359931) Subject | Form SCHEDULE 13G | |
| 02/25/2026 6:57 PM | Baker Brothers Life Sciences LP (1363364) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 6:58 PM | 667, L.P. (1551139) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 8:13 PM | 667, L.P. (1551139) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 8:11 PM | Baker Brothers Life Sciences LP (1363364) Reporting Protara Therapeutics (1359931) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Your Social Security check is scheduled for a 22% cut (Ad) The U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt death spiral. Interest payments alone now top a trillion dollars a year.
The Social Security trust fund is projected to run dry by 2032, which could trigger an automatic 22% cut to benefits. Between 2020 and 2022, the Fed expanded the money supply by 41%.
A free 27 page report breaks down these numbers in plain English, including what central banks have been doing with gold. Download the free Debt Death Spiral report now |
| 02/24/2026 7:52 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/22/2026 3:30 PM | Fry Hannah (1938146) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 3:30 PM | Protara Therapeutics (1359931) Issuer Zummo Jacqueline (1798929) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 3:30 PM | Fabbio Patrick (1658859) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/22/2026 3:30 PM | Protara Therapeutics (1359931) Issuer Shefferman Jesse (1799167) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:36 PM | Protara Therapeutics (1359931) Issuer Zummo Jacqueline (1798929) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:36 PM | Protara Therapeutics (1359931) Issuer Shefferman Jesse (1799167) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:36 PM | Nicacio Leonardo Viana (2064901) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:36 PM | Fry Hannah (1938146) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:37 PM | Fabbio Patrick (1658859) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/21/2026 3:37 PM | CONKLING WILLIAM (1852018) Reporting Protara Therapeutics (1359931) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/15/2025 3:15 PM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/08/2025 3:15 PM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/05/2025 3:29 PM | Protara Therapeutics (1359931) Filer | Form 424B5 | |
| 12/03/2025 7:08 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/19/2025 8:15 AM | Protara Therapeutics (1359931) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |